In the present study, we examined PIK3CA gene mutation, PIK3CA amplification as well as the expression of PI3K p110α, p-Akt, mTOR and PTEN which lie in the PI3K pathway in a consecutive collection of NSCLC tumor samples. This evidence concerns the gene MTOR and non-small cell lung carcinoma.